Correction to: Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and tankyrase inhibitors (Journal of Medicinal Chemistry (2017) 60: 4 (1262-1271) DOI: 10.1021/acs.jmedchem.6b00990)

Ann Gerd Thorsell, Torun Ekblad, Tobias Karlberg, Mirjam Löw, Ana Filipa Pinto, Lionel Trésaugues, Martin Moche, Michael S. Cohen, Herwig Schüler

Research output: Contribution to journalComment/debatepeer-review

Abstract

Page 1264. Table 2, line 10 ("PARP4/ART"), column 14 ("PJ34/IC50") should be "760" instead of blank. Page 1264. Table 2, line 16 ("PARP12/ART"), column 6 ("Niraparib/IC50") should be "790" instead of "79". Page 1264. Table 2, line 17 ("PARP14/ART"), column 6 ("Niraparib/IC50") should be "1730" instead of "17300".

Original languageEnglish (US)
Pages (from-to)5922
Number of pages1
JournalJournal of Medicinal Chemistry
Volume62
Issue number12
DOIs
StatePublished - Jun 27 2019

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Correction to: Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and tankyrase inhibitors (Journal of Medicinal Chemistry (2017) 60: 4 (1262-1271) DOI: 10.1021/acs.jmedchem.6b00990)'. Together they form a unique fingerprint.

Cite this